For example, a recent study by Gabriel et al. (2013) demonstrated that EVs derived from various cancer cell lines and PC patients' plasma contained a functionally active tumour-suppressor protein PTEN that suppressed the proliferation of PTEN-deficient recipient cells [107]. This evidence concerns the gene PTEN and neoplasm.